Lombard Odier Asset Management (Switzerland) Sa Amgen Inc Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.93 Billion
Q2 2025

A detailed history of Lombard Odier Asset Management (Switzerland) Sa transactions in Amgen Inc stock. As of the latest transaction made, Lombard Odier Asset Management (Switzerland) Sa holds 30,088 shares of AMGN stock, worth $8.98 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

30,088

Previous 28,390 5.98%

Holding current value

$8.98 Million

Previous $8.84 Million 5.02%

% of portfolio

0.44%

Previous 0.54%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$262.28 - $309.85 $445,351 - $526,125	1,698 Added 5.98%	30,088 $8.4 Million
Q1 2025 May 15, 2025	BUY	$258.59 - $327.36 $3.76 Million - $4.76 Million	14,552 Added 105.16%	28,390 $8.84 Million
Q4 2024 Feb 14, 2025	BUY	$258.78 - $328.31 $366,691 - $465,215	1,417 Added 11.41%	13,838 $3.61 Million
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $1.05 Million - $1.15 Million	-3,409 Reduced 21.54%	12,421 $4 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $144,775 - $175,939	-551 Reduced 3.36%	15,830 $4.95 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $4.4 Million - $5.32 Million	16,381 New	16,381 $4.66 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $35,223 - $42,931	156 Added 3.37%	4,787 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $510,278 - $648,370	2,228 Added 92.72%	4,631 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $414,802 - $467,821	-1,848 Reduced 43.47%	2,403 $542,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $980,748 - $1.09 Million	4,251 New	4,251 $1.03 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $1.21 Million - $1.34 Million	-5,519 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.1 Million - $1.26 Million	5,519 New	5,519 $1.24 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.58 Million - $1.85 Million	-7,450 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $406,429 - $450,903	1,740 Added 30.47%	7,450 $1.82 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $1.27 Million - $1.48 Million	5,710 New	5,710 $1.42 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $2.18 Million - $2.6 Million	-10,074 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $2.36 Million - $2.63 Million	10,074 New	10,074 $2.56 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.84 Million - $2.26 Million	-9,316 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $447,581 - $593,615	-2,456 Reduced 20.86%	9,316 $1.89 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.44 Million - $1.85 Million	7,591 Added 181.56%	11,772 $2.84 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $628,188 - $752,700	-3,608 Reduced 46.32%	4,181 $809,000
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $7,501 - $8,793	-45 Reduced 0.57%	7,789 $1.44 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $42,685 - $48,115	-236 Reduced 2.92%	7,834 $1.49 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $1.08 Million - $1.26 Million	-6,050 Reduced 42.85%	8,070 $1.57 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $619,239 - $698,110	3,342 Added 31.01%	14,120 $2.93 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $1.79 Million - $2.01 Million	10,778 New	10,778 $1.99 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $551,155 - $644,094	-3,253 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $544,194 - $621,323	3,253	3,253 $607,000

Others Institutions Holding AMGN

# of Institutions

3,287

Shares Held

439M

Call Options Held

6.26M

Put Options Held

7.38M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $160B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account

Lombard Odier Asset Management (Switzerland) Sa Amgen Inc Transaction History